Global Drugs for Malaria Market 2018 by Players, States, Type, Application, Forecast to 2023

The Drugs for Malaria Research Report describe Industry Introduction, Product Scope, Market Overview, Opportunities, Market Risk, Driving Force. Global Market analyze by top manufacturers, by regions, by type and application. The report will include the qualitative and quantitative analysis with market estimation over 2018 – 2023 and compound annual growth rate (CAGR) between 2018 and 2023.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Scope of the Report:
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Market Segment by Manufacturers, this report covers
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Market Segment by Applications, can be divided into
Prevention
Treatment
Other

There are 15 Chapters to deeply display the global Drugs for Malaria market.
Chapter 1, to describe Drugs for Malaria Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Malaria, with sales, revenue, and price of Drugs for Malaria, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Malaria, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Cipla
2.1.1 Business Overview
2.1.2 Drugs for Malaria Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Guilin Pharmaceutical
2.2.1 Business Overview
2.2.2 Drugs for Malaria Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 IPCA Laboratories
2.3.1 Business Overview
2.3.2 Drugs for Malaria Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Drugs for Malaria Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan Labs
2.5.1 Business Overview
2.5.2 Drugs for Malaria Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Drugs for Malaria Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Drugs for Malaria Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi Aventis
2.8.1 Business Overview
2.8.2 Drugs for Malaria Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ajanta Pharma
2.9.1 Business Overview
2.9.2 Drugs for Malaria Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drugs for Malaria Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Malaria Manufacturer Market Share
3.3.2 Top 6 Drugs for Malaria Manufacturer Market Share
3.4 Market Competition Trend

4 Global Drugs for Malaria Market Analysis by Regions
4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Malaria Sales and Market Share by Regions (2013-2018)
4.1.2 Global Drugs for Malaria Revenue and Market Share by Regions (2013-2018)
4.2 North America Drugs for Malaria Sales and Growth Rate (2013-2018)
4.3 Europe Drugs for Malaria Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Malaria Sales and Growth Rate (2013-2018)
4.5 South America Drugs for Malaria Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

5 North America Drugs for Malaria by Countries
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Malaria Sales and Market Share by Countries (2013-2018)
5.1.2 North America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)
5.2 United States Drugs for Malaria Sales and Growth Rate (2013-2018)
5.3 Canada Drugs for Malaria Sales and Growth Rate (2013-2018)
5.4 Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)

6 Europe Drugs for Malaria by Countries
6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Malaria Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Drugs for Malaria Revenue and Market Share by Countries (2013-2018)
6.2 Germany Drugs for Malaria Sales and Growth Rate (2013-2018)
6.3 UK Drugs for Malaria Sales and Growth Rate (2013-2018)
6.4 France Drugs for Malaria Sales and Growth Rate (2013-2018)
6.5 Russia Drugs for Malaria Sales and Growth Rate (2013-2018)
6.6 Italy Drugs for Malaria Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drugs for Malaria by Countries
7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Countries (2013-2018)
7.2 China Drugs for Malaria Sales and Growth Rate (2013-2018)
7.3 Japan Drugs for Malaria Sales and Growth Rate (2013-2018)
7.4 Korea Drugs for Malaria Sales and Growth Rate (2013-2018)
7.5 India Drugs for Malaria Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)

8 South America Drugs for Malaria by Countries
8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Malaria Sales and Market Share by Countries (2013-2018)
8.1.2 South America Drugs for Malaria Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)
8.3 Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)
8.4 Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drugs for Malaria by Countries
9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Malaria Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Malaria Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)
9.3 UAE Drugs for Malaria Sales and Growth Rate (2013-2018)
9.4 Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)
9.5 Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)
9.6 South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)

10 Global Drugs for Malaria Market Segment by Type
10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)
10.2 Aryl Aminoalcohol Compounds Sales Growth and Price
10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)
10.2.2 Global Aryl Aminoalcohol Compounds Price (2013-2018)
10.3 Antifolate Compounds Sales Growth and Price
10.3.1 Global Antifolate Compounds Sales Growth (2013-2018)
10.3.2 Global Antifolate Compounds Price (2013-2018)
10.4 Artemisinin Compounds Sales Growth and Price
10.4.1 Global Artemisinin Compounds Sales Growth (2013-2018)
10.4.2 Global Artemisinin Compounds Price (2013-2018)

11 Global Drugs for Malaria Market Segment by Application
11.1 Global Drugs for Malaria Sales Market Share by Application (2013-2018)
11.2 Prevention Sales Growth (2013-2018)
11.3 Treatment Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)

12 Drugs for Malaria Market Forecast (2018-2023)
12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Malaria Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Malaria Market Forecast (2018-2023)
12.2.2 Europe Drugs for Malaria Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2018-2023)
12.2.4 South America Drugs for Malaria Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2018-2023)
12.3 Drugs for Malaria Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Malaria Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2018-2023)
12.4 Drugs for Malaria Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Malaria Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Data Source


Your Name (required)

Your Email (required)

Telephone Number (required)

Name of company (required)

Country Name (required)

How can we help you?